Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. | 0 | reported | 16 Sept 2025 | tx 205+2,721,008−4,724,209 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Sept 2025 | TENDER | Y-mAbs Therapeutics, Inc. | 60,000 | 8.60 USD | |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 60,235 | — | |
| 16 Sept 2025 | TENDER | Y-mAbs Therapeutics, Inc. | 245,486 | 8.60 USD | |
| 16 Sept 2025 | TENDER | Y-mAbs Therapeutics, Inc. | 67,681 | 8.60 USD | |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 60,000 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 110,000 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 91,450 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 130,000 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 107,500 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 100,000 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 16,000 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 143,169 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 16,000 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 16,000 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 64,000 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 132,500 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 242,200 | — | deriv |
| 16 Sept 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 75,000 | — | deriv |
| 03 Jun 2025 | EXERCISE | Y-mAbs Therapeutics, Inc. | 103,000 | 2.00 USD | |
| 03 Jun 2025 | EXERCISE | Y-mAbs Therapeutics, Inc. | 103,000 | 0.00 USD | deriv |
| 07 Mar 2025 | SALE | Y-mAbs Therapeutics, Inc. | 10,810 | 5.23 USD | |
| 17 Jan 2025 | GRANT_AWARD | Y-mAbs Therapeutics, Inc. | 32,000 | 0.00 USD | |
| 17 Jan 2025 | GRANT_AWARD | Y-mAbs Therapeutics, Inc. | 64,000 | 0.00 USD | deriv |
| 19 Sept 2024 | EXERCISE | Y-mAbs Therapeutics, Inc. | 22,831 | 4.38 USD | |
| 19 Sept 2024 | EXERCISE | Y-mAbs Therapeutics, Inc. | 22,831 | 0.00 USD | deriv |